Results 51 to 60 of about 25,627,615 (299)

Evaluating the Utility of Paired Tumor and Germline Targeted DNA Sequencing for Pediatric Oncology Patients: A Single Institution Report

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate the diagnostic yield and utility of universal paired tumor–normal multigene panel sequencing in newly diagnosed pediatric solid and central nervous system (CNS) tumor patients and to compare the detection of germline pathogenic/likely pathogenic variants (PV/LPVs) against established clinical referral criteria for cancer ...
Natalie Waligorski   +9 more
wiley   +1 more source

Adherence to exercise referral schemes by participants – what do providers and commissioners need to know? A systematic review of barriers and facilitators

open access: yesBMC Public Health, 2016
Background Physical inactivity levels are rising worldwide with major implications for the health of the population and the prevalence of non-communicable diseases.
Fiona Morgan   +7 more
doaj   +1 more source

Analysis of the Korean generic medicine market: Factors affecting the market share of generic medicines

open access: yesClinical and Translational Science, 2022
This study probed the market share of generic medicines by patients’ age and sex, type of medical facilities, route of administration, number of generic brands, market size (drug expenditure), and therapeutic class and investigated factors associated ...
Dong‐Sook Kim, Jihye Shin, Jusun Chung
doaj   +1 more source

Preferences of Pediatric Patients and Their Caregivers for Chemotherapy‐Induced Nausea and Vomiting Control Endpoints: A Mixed Methods Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Although not always achieved, complete chemotherapy‐induced nausea and vomiting (CINV) control is the conventional goal of CINV prophylaxis. In this two‐center, mixed‐methods study, we sought to understand the preferences of adolescent patients and family caregivers for CINV control endpoints.
Haley Newman   +8 more
wiley   +1 more source

History of OWGA Is Noted Article [PDF]

open access: yes, 1970
The Oregon Wine Grower\u27s Association (OWGA) was created in January 1969 with Paul Bjelland as President, Richard Sommer as Vice President, Ted Anderson, Jr. as Secretary, and Dr. T. R. Mafit as Treasurer.
The News-Review
core   +1 more source

Intravitreal GD2‐Specific Chimeric Antigen Receptor T‐Cell Therapy for Refractory Retinoblastoma

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Effective treatments for advanced, treatment‐resistant retinoblastoma (RB) remain limited. GD2‐specific chimeric antigen receptor (CAR) T cells show potent antitumor activity with minimal toxicity but have not previously been evaluated in RB.
Subongkoch Subhadhirasakul   +13 more
wiley   +1 more source

Editorial: Insights (January 2021)

open access: yesTechnology Innovation Management Review, 2021
Stoyan Tanev, Gregory Sandstrom
doaj   +1 more source

Bjelland Awaits Anniversary Article [PDF]

open access: yes, 1975
This captioned photo collage from the Roseburg News-Review marks the upcoming fifth anniversary for Bjelland Vineyards on October 12, 1975.
The News-Review
core   +1 more source

Outcomes of Live Virus Vaccination in Patients With Vascular Anomalies Being Treated With Sirolimus

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Live vaccination in patients with vascular anomalies (VA) receiving sirolimus remains controversial due to immunosuppressive effects and theoretical risks. Procedure This single‐center retrospective study included patients with VA less than 4 years old at the start of sirolimus therapy who were incompletely vaccinated.
Svatava Merkle   +5 more
wiley   +1 more source

Rock Marks Vineyard Site Article [PDF]

open access: yes, 1970
The location of Bjelland Vineyards is marked by a rock in Roseburg, Oregon. In 1970, Bjelland Vineyards began planning construction of a winery at the vineyard site.
The News-Review
core   +1 more source

Home - About - Disclaimer - Privacy